IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
IMPL
Delisted
IMPL was delisted on the 15th of December, 2023.
44 hedge funds and large institutions have $222M invested in Impel Pharmaceuticals Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
44
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$4.06M | |
| 2 | +$3.78M | |
| 3 | +$2.44M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.2M |
| 5 |
DA
DCF Advisers
Greenwich,
Connecticut
|
+$1.83M |
Top Sellers
| 1 | -$2.02M | |
| 2 | -$394K | |
| 3 | -$240K | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$238K |
| 5 |
ZP
Zimmer Partners
New York
|
-$221K |